JENNY QUEEN: Open Payments
NPI 1437113578 · GLENWOOD SPRINGS, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$553 in 25 payments from 12 companies in 2025. Trend: 2023 $331 · 2024 $766 · 2025 $553
Food & beverage: $553
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $109 |
| Insmed, Inc. | 4 | $108 |
| GlaxoSmithKline, LLC. | 4 | $73 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $54 |
| Merck Sharp & Dohme LLC | 2 | $41 |
| Verona Pharma, Inc. | 2 | $41 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $25 |
| Actelion Pharmaceuticals US, Inc. | 1 | $23 |
| Regeneron Healthcare Solutions, Inc. | 1 | $22 |
| Pulmonx Corporation | 1 | $20 |
Products named: Arikayce, TEZSPIRE, NUCALA, WINREVAIR, Ohtuvayre, JASCAYD, AIRSUPRA, GLASSIA.
Industry payments across CO — which companies pay providers there.
